Fcγ receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity

Author： Tedder Thomas Baras Aris Xiu Yan

Publisher： Springer Publishing Company

ISSN： 0344-4325

Source： Springer Seminars in Immunopathology, Vol.28, Iss.4, 2006-12, pp. : 351-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FcγRIIb inhibits both B cell receptor- and CD19-induced Ca 2+ mobilization in FcγR-transfected human B cells

By Koncz G.

International Immunology, Vol. 10, Iss. 2, 1998-02 ,pp. : 141-146

Oxford University Press

Access to resources Recommend Favorite

BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression

By Nikolova M. Marie-Cardine A. Boumsell L. Bensussan A.

International Immunology, Vol. 14, Iss. 5, 2002-05 ,pp. : 445-451

Oxford University Press

Access to resources Recommend Favorite

CD27/CD70 interactions regulate T dependent B cell differentiation

By Jacquot Serge

Immunologic Research, Vol. 21, Iss. 1, 2000-02 ,pp. : 23-30

Humana Press, Inc

Access to resources Recommend Favorite

CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification

By Fujimoto Manabu Poe Jonathan Hasegawa Minoru Tedder Thomas

Immunologic Research, Vol. 22, Iss. 2-3, 2000-12 ,pp. : 281-298

Humana Press, Inc

Access to resources Recommend Favorite

The molecular mechanisms that control function and death of effector CD4⁺ T cells

By Lu Binfeng

Immunologic Research, Vol. 36, Iss. 1-3, 2006-02 ,pp. : 275-282

Humana Press, Inc

Access to resources Recommend Favorite